San Diego Private Bank Second Quarter Earnings CORONADO,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
San Diego Private Bank Second Quarter Earnings

CORONADO, CA--(Marketwired - Aug 5, 2013) - Maria P. Kunac, President and Chief Executive Officer of San Diego Private Bank ( OTCQB : SDPB ), announced today the bank's condition and results of operations for second quarter 2013. This is the first quarterly report of the combined Coronado First Bank and San Diego Private Bank since the merger completed April 2, 2013. 

Based on unaudited financial results for the second quarter ended June 30, 2013, San Diego Private Bank reported net profit of $253,000 for the quarter, after merger related expenses and accounting adjustments. 

Maria P. Kunac, President and CEO, stated, "We are very pleased with the progress of integrating San Diego Private Bank and Coronado First Bank. With increased credit capacity and expanded service offerings through our branches in Coronado, downtown San Diego, La Jolla and Newport Beach, as well as our SBA Office in San Marcos, we saw an increase in both loans and deposits this quarter. We expect to build on this momentum in the third quarter as southern California economic fundamentals improve."

 
San Diego Private Bank
Balance Sheet
(Unaudited - 000's Omitted)
 
    June 30, 2013   June 30, 2012
Assets            
Cash and Cash Equivalents   $ 80,645   $ 35,703
Investments     20,131     6,707
Loans, Net     201.360     110,717
Premises, Equipment and Other Assets     11,204     6,543
  Total Assets   $ 313,340   $ 159,670
             
Liabilities and Shareholders' Equity            
Demand Deposits     84,052     16,704
Interest Bearing Deposits     167,854     103,336
  Total Deposits     251,906     120,041
             
FHLB Advances / Borrowings     13,242     10,000
Other Liabilities     2,382     1,640
Shareholders' Equity     45,810     27,989
  Total Liabilities and Shareholders' Equity   $ 313,340   $ 159,670
             
             
             
San Diego Private Bank
Income Statements
(Unaudited - 000's Omitted)
 
    3 months ending June 30, 2013   6 months ending June 30, 2013   3 months ending June 30, 2012   6 months ending June 30, 2012
Interest Income                        
Interest Income     3,121     5,051     1,961     3,993
Interest Expense     326     603     273     527
  Net Interest Income     2,795     4,448     1,688     3,466
Provision for Loan Losses     173     240     181     186
  Net Interest Income after Provision for Loan Losses     2,622     4,208     1,507     3,280
Other Income     660     835     165     202
Operating Expenses     2,824     3,946     1,101     2,485
  Operating Income     458     1,097     571     997
Income Taxes     215     521     242     424
  Net Earnings   $ 243   $ 576   $ 329   $ 573
                         
Selected Ratios:                        
Earnings Per Share   $ 0.06   $ 0.17   $ 0.12   $ 0.22
(Weighted Average Shares)                        
Tangible Book Value Per Share         $ 11.15         $ 10.77
Tier 1 Leverage Ratio           14.08%           16.58%
Total Risk Based Capital Ratio           21.22%           23.83%
                         
Asset Quality                        
(Non-Performing Assets + 90 Days Past Due Accruing) divided by (Equity + Allowance for Loan Losses)           2.80%           1.56%
                         

San Diego Private Bank is publicly traded on the Over-the-Counter Bulletin Board, ticker symbol: "SDPB". Total shares outstanding of San Diego Private Bank stock are 4,053,809 as of 6/30/13.

This press release may include forward‐looking statements that involve inherent risks and uncertainties, including the anticipated benefits to be achieved as a result of the merger, the successful integration of the two banks, the equity capital of the combined bank, the potential returns on investment of shareholders, economic conditions and competition in the geographic and business areas in which the Bank operates, inflation, fluctuations in interest rates, legislation and governmental regulation. These statements are subject to risks and uncertainties and actual results could differ materially due to certain risk factors. You should not place undue reliance on forward‐looking statements and we undertake no obligation to update those statements whether as a result of changes in underlying factors, new information, future events or otherwise.

Investor Relations Contact Maria P. Kunac President and Chief Executive Officer San Diego Private Bank (858) 875.6900 www.sandiegoprivatebank.net

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 455

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 258

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 501

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 431

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 427

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 330

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 90

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 305

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 631

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading

Top 5 Most Recently Viewed Articles

Daily Insights on WisdomTree Fund Prices and Holdings Update

Updated Category News Views 284

WisdomTree Fund Prices Overview In today’s ever-evolving financial landscape, understanding fund prices is crucial for investors. WisdomTree Issuer plc offers a range of funds that are pivotal to the investment strategy of many. With the latest updates from the fund market, let's delve into the details of some notable WisdomTree funds available for investment. Key...

Continue Reading
Impact of Drug Tariffs on American Patients and Insurers

Updated Category News Views 290

Understanding the Proposed Drug Tariffs Introduced by the Administration Recent discussions have centered around proposed 100% tariffs on foreign pharmaceuticals, primarily advocated by the administration. Economists warn that these tariffs will place a heavy financial burden on American patients and insurers rather than the foreign drug manufacturers. Economic Insights...

Continue Reading
AvidXchange Q2 2025 Results: Growth Amid Strategic Changes

Updated Category News Views 445

AvidXchange Reports Strong Financial Growth in Q2 2025 AvidXchange Holdings, Inc. (Nasdaq: AVDX), a leader in accounts payable (AP) automation software, has published its financial results for the second quarter ended June 30, 2025. The company showcases growth despite various strategic changes, particularly surrounding its pending acquisition. Financial Highlights for Q2...

Continue Reading
Talkiatry Ranks #6 in Digital Health Innovation for 2024

Updated Category News Views 552

Talkiatry Achieves Recognition in Digital Health Talkiatry has been honored as the sixth most innovative digital health startup for 2024. This accolade is a testament to the significant impact the organization is making in the field of behavioral health care. Significance of the CB Insights Ranking Chosen by CB Insights, Talkiatry's ranking reflects a combination of...

Continue Reading
Innovative Partnership Enhances SBA Loan Accessibility for Businesses

Updated Category News Views 267

BizBuySell and LoanBud Collaboration Enhances Financing for Businesses BizBuySell, the leading business-for-sale marketplace, has teamed up with LoanBud, a fintech innovator specializing in SBA financing. This collaboration significantly transforms the experience of buying or selling small businesses by increasing transparency and clarity in the financing process from the...

Continue Reading